CRA-026440

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCRA-026440
Drug Alias NameCRA-026440
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 6 inhibitorsHistone deacetylase 3 inhibitorsHistone deacetylase 8 inhibitors +[5] 
TargetsHistone deacetylase 3Histone deacetylase 1Histone deacetylase 6 +[5] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelera
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeleraPharmacyclics Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A